Huma Therapeutics

Huma Therapeutics is a digital health company founded in 2011, growing out of research links to Johns Hopkins University and the University of Oxford, and now headquartered in London, United Kingdom. It was built to help regulated health systems, pharmaceutical companies and governments deploy compliant AI-driven clinical software without building remote monitoring and trial infrastructure in-house.

Its core product, the Huma Operating System, is a cloud platform with modules such as Huma Workspace for configuring regulated clinical apps without custom code, Huma Intelligence for AI-assisted clinical decision support, remote patient monitoring for chronic and post-acute care, and the Alcedis module for decentralized clinical trial data collection. Customers include NHS England, hospital networks such as Banner Medical Group, and pharmaceutical companies including Bayer, AstraZeneca and Servier, across 70+ countries.

1. No-code app builder: Huma Workspace lets health organizations configure regulated clinical apps without custom coding.

2. Remote patient monitoring: captures vital signs and patient-reported outcomes between visits for chronic and post-acute care.

3. Clinical decision support: Huma Intelligence surfaces AI-driven insights from aggregated patient data for clinicians.

4. Virtual clinical trials: the Alcedis module supports decentralized trial data collection for pharmaceutical sponsors.

5. Primary care triage: the A&E eTriage module helps services prioritize patients before consultation.

6. Global deployment: the platform runs across 70+ countries under local data protection and medical device rules.